Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-213019
Filing Date
2004-12-15
Accepted
2004-12-14 20:23:28
Documents
7
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 906731
2 LIST OF SUBSIDIARIES dex21.htm EX-21 1734
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 2205
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 9204
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 9208
6 CERTIFICATION BY GLENN L. COOPER, CEO dex321.htm EX-32.1 2677
7 CERTIFICATION BY MICHAEL W. ROGERS, CFO dex322.htm EX-32.2 2683
  Complete submission text file 0001193125-04-213019.txt   936907
Mailing Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421
Business Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Filer) CIK: 0000854222 (see all company filings)

EIN.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-18728 | Film No.: 041203010
SIC: 2834 Pharmaceutical Preparations